We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-7.91%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$116M
AUM Growth
+$9.76M
Cap. Flow
+$11.9M
Cap. Flow %
10.24%
Top 10 Hldgs %
77.9%
Holding
189
New
31
Increased
1
Reduced
48
Closed
45

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 46.25%
2 Healthcare 15.17%
3 Financials 14.14%
4 Industrials 3.87%
5 Consumer Staples 1.67%

No holdings matched the selected filter criteria.

Similar funds

CVI Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, CVI Holdings held 189 positions worth $116M, up 9.2% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings deployed $11.9M of net new capital in Q2 2024, opening 31 new positions and adding to 1 existing holding. Its largest new stake was Skye Bioscience: 679,739 shares worth $5.44M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 55% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Achieve Life Sciences, an estimated $2.39M trimmed.

  • CVI Holdings's largest Q2 2024 buy was Skye Bioscience: 679,739 shares worth $5.44M.
  • CVI Holdings added most to RTB Digital in Q2 2024, an estimated $151K increase.
  • CVI Holdings's biggest Q2 2024 reduction was Achieve Life Sciences, cutting an estimated $2.39M.
  • CVI Holdings fully exited Spire Global in Q2 2024, selling an estimated $3.13M.
  • CVI Holdings's ten largest holdings make up 78% of its $116M portfolio in Q2 2024.
  • CVI Holdings opened 31 new positions and closed 45 in Q2 2024.
  • CVI Holdings's portfolio value rose 9.2% quarter-over-quarter to $116M.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.